Multiple-Comparison Modeling Improves Dose Selection: EMA

Clinical Trials Advisor
Use of the “multiple comparison procedure – modeling,” or MCP-Mod, approach to dose response testing and estimation provides a “more solid basis” for Phase III dose selection, the European Medicines Agency says in a recently posted draft opinion on the methodology.

To View This Article:


Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00